作为具有抗转移性质的新选择性抗癌剂的伊米达-2-衍生物:合成和药理学评估
Božena Golcienė1, Natalia Maciejewska2, Anoop Kallingal2
1Department of Organic Chemistry, Kaunas University of Technology, Kaunas, Lithuania.
Journal of enzyme inhibition and medicinal chemistry
|January 6, 2026
概括
一种新型的伊米达衍生物,化合物24,通过诱导细胞死亡和抑制癌细胞迁移和入侵,显示出强大的抗癌作用. 这种化合物显示出作为多种癌症的双重作用治疗剂的前景.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊米达支架在药物发现中是有价值的,因为它们的生物活性和易于合成.
- 开发具有双重细胞毒性和抗转移性质的新型抗癌药物是瘤学的一个关键目标.
研究的目的:
- 合成和评估S替代的伊米达-2-衍生物作为潜在的抗癌剂.
- 在癌症模型中研究化合物24的细胞毒性和抗转移机制.
主要方法:
- 意达-2-衍生物的合成和化合物的表征 24.
- 在体外细胞毒性测试,细胞周期分析,细胞亡测试和迁移/入侵测试.
- 在体内研究使用胚胎胆 ?? 质膜 (CAM) 模型和分子对接模拟.
主要成果:
- 化合物24对肺癌,宫癌和结直肠癌细胞表现出强烈的亚微粒细胞毒性,对正常纤维细胞具有选择性.
- 机制包括G1细胞周期停止,酶依赖的亡,以及抑制癌细胞迁移和入侵.
- 化合物24低调矩阵金属蛋白酶 (MMP-2,MMP-9) 和人类端粒酶逆转录酶 (hTERT),直接抑制MMP-9的活性.
- 在体内,化合物24抑制了CAM模型中的瘤生长和转移,没有可观察到的毒性.
结论:
- 化合物24具有显著的细胞毒性和抗转移性质,使其成为进一步临床前抗癌药物开发的有希望的候选者.
- 化合物24的双重作用保证了其在各种癌症中的治疗潜力的继续调查.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
801
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
801
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
594
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
594
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581


